429 related articles for article (PubMed ID: 31214623)
1. Celiac Disease in Children, Particularly with Accompanying Type 1 Diabetes, Is Characterized by Substantial Changes in the Blood Cytokine Balance, Which May Reflect Inflammatory Processes in the Small Intestinal Mucosa.
Vorobjova T; Tagoma A; Oras A; Alnek K; Kisand K; Talja I; Uibo O; Uibo R
J Immunol Res; 2019; 2019():6179243. PubMed ID: 31214623
[TBL] [Abstract][Full Text] [Related]
2. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.
Vorobjova T; Uibo O; Heilman K; Uibo R
World J Gastroenterol; 2015 Jan; 21(2):439-52. PubMed ID: 25593459
[TBL] [Abstract][Full Text] [Related]
3. Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients.
Vorobjova T; Raikkerus H; Kadaja L; Talja I; Uibo O; Heilman K; Uibo R
Dig Dis Sci; 2017 Feb; 62(2):358-371. PubMed ID: 27995404
[TBL] [Abstract][Full Text] [Related]
4. The impact of langerin (CD207)+ dendritic cells and FOXP3+ Treg cells in the small bowel mucosa of children with celiac disease and atopic dermatitis in comparison to children with functional gastrointestinal disorders.
Vorobjova T; Ress K; Luts K; Uibo O; Uibo R
APMIS; 2016 Aug; 124(8):689-96. PubMed ID: 27200487
[TBL] [Abstract][Full Text] [Related]
5. Lower expression of tight junction protein 1 gene and increased FOXP3 expression in the small bowel mucosa in coeliac disease and associated type 1 diabetes mellitus.
Vorobjova T; Uibo O; Ojakivi I; Teesalu K; Panarina M; Heilman K; Uibo R
Int Arch Allergy Immunol; 2011; 156(4):451-61. PubMed ID: 21832836
[TBL] [Abstract][Full Text] [Related]
6. Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus.
Vorobjova T; Uibo O; Heilman K; Rägo T; Honkanen J; Vaarala O; Tillmann V; Ojakivi I; Uibo R
Scand J Gastroenterol; 2009; 44(4):422-30. PubMed ID: 19096978
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease.
Borrelli M; Salvati VM; Maglio M; Zanzi D; Ferrara K; Santagata S; Ponticelli D; Aitoro R; Mazzarella G; Lania G; Gianfrani C; Auricchio R; Troncone R
Am J Gastroenterol; 2013 Nov; 108(11):1775-84. PubMed ID: 24060758
[TBL] [Abstract][Full Text] [Related]
8. Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity?
Uibo R; Panarina M; Teesalu K; Talja I; Sepp E; Utt M; Mikelsaar M; Heilman K; Uibo O; Vorobjova T
Cell Mol Immunol; 2011 Mar; 8(2):150-6. PubMed ID: 21317917
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes.
Tiittanen M; Westerholm-Ormio M; Verkasalo M; Savilahti E; Vaarala O
Clin Exp Immunol; 2008 Jun; 152(3):498-507. PubMed ID: 18435801
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
[TBL] [Abstract][Full Text] [Related]
11. Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria.
Sjöberg V; Sandström O; Hedberg M; Hammarström S; Hernell O; Hammarström ML
PLoS One; 2013; 8(1):e53414. PubMed ID: 23326425
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes.
Lahdenperä AI; Hölttä V; Ruohtula T; Salo HM; Orivuori L; Westerholm-Ormio M; Savilahti E; Fälth-Magnusson K; Högberg L; Ludvigsson J; Vaarala O
Clin Exp Immunol; 2012 Feb; 167(2):226-34. PubMed ID: 22235998
[TBL] [Abstract][Full Text] [Related]
13. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
[TBL] [Abstract][Full Text] [Related]
14. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
15.
Zhao Q; Yang WR; Wang XH; Li GQ; Xu LQ; Cui X; Liu Y; Zuo XL
World J Gastroenterol; 2019 Sep; 25(36):5469-5482. PubMed ID: 31576093
[TBL] [Abstract][Full Text] [Related]
16. Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis.
Yu S; Han B; Liu S; Wang H; Zhuang W; Huang Y; Zhang R
Mol Immunol; 2017 Oct; 90():172-181. PubMed ID: 28802126
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
18. Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum.
Montalvillo E; Bernardo D; Martínez-Abad B; Allegretti Y; Fernández-Salazar L; Calvo C; Chirdo FG; Garrote JA; Arranz E
Nutrients; 2015 Oct; 7(11):8960-76. PubMed ID: 26529008
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes.
Kikodze N; Pantsulaia I; Rekhviashvili Kh; Iobadze M; Dzhakhutashvili N; Pantsulaia N; Kukuladze N; Bikashvili N; Metreveli D; Chikovani T
Georgian Med News; 2013 Sep; (222):29-35. PubMed ID: 24099812
[TBL] [Abstract][Full Text] [Related]
20. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.
Vinderola G; Perdigón G; Duarte J; Farnworth E; Matar C
Cytokine; 2006 Dec; 36(5-6):254-60. PubMed ID: 17363262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
